Correspondence 0001193125-24-118308 from Whitehawk Therapeutics, Inc. (WHWK)
Whitehawk Therapeutics, Inc.
Date: April 26, 2024 · CIK: 0001422142 · Accession: 0001193125-24-118308
AI Filing Summary & Sentiment
File numbers found in text: 333-277018
Letter
Re: Aadi Bioscience, Inc.
April 26, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Joshua Gorsky
Registration Statement on Form S-3
File No. 333-277018
Acceleration Request
Requested Date:
April 30, 2024
Requested Time:
4:00 p.m. Eastern Time, or as soon thereafter as practicable
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Aadi Bioscience, Inc. (the “Company”) hereby requests that its Registration Statement on Form S-3 (File No. 333-277018) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Robert Wernli at (858) 350-2273.
Sincerely,
AADI BIOSCIENCE, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP April 26, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Joshua Gorsky Re: Aadi Bioscience, Inc. Registration Statement on Form S-3 File No. 333-277018 Acceleration Request Requested Date: April 30, 2024 Requested Time: 4:00 p.m. Eastern Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Aadi Bioscience, Inc. (the “Company”) hereby requests that its Registration Statement on Form S-3 (File No. 333-277018) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Robert Wernli at (858) 350-2273. Sincerely, AADI BIOSCIENCE, INC. By: /s/ David Lennon David Lennon Chief Executive Officer cc: Steve Rodin, Aadi Bioscience, Inc. Dan Koeppen, Wilson Sonsini Goodrich & Rosati Robert Wernli, Wilson Sonsini Goodrich & Rosati